Following the lead of Juno Therapeutics and Kite Pharma, CAR-T contender Bellicum Pharmaceuticals is splashing cash on an in-house manufacturing operation, speeding its cell therapies into clinical trials in a host of cancers.

…read more

Source: Bellicum buys into CAR-T manufacturing amid a hot immuno-oncology race


0 No comments